JPS50148349A - - Google Patents

Info

Publication number
JPS50148349A
JPS50148349A JP50045924A JP4592475A JPS50148349A JP S50148349 A JPS50148349 A JP S50148349A JP 50045924 A JP50045924 A JP 50045924A JP 4592475 A JP4592475 A JP 4592475A JP S50148349 A JPS50148349 A JP S50148349A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50045924A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50148349A publication Critical patent/JPS50148349A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP50045924A 1974-04-17 1975-04-17 Pending JPS50148349A (2)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
JPS50148349A true JPS50148349A (2) 1975-11-27

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50045924A Pending JPS50148349A (2) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (2)
JP (1) JPS50148349A (2)
AR (1) AR208545A1 (2)
CA (1) CA1047042A (2)
CH (1) CH611292A5 (2)
DD (1) DD117223A5 (2)
DE (1) DE2516554A1 (2)
DK (1) DK164175A (2)
ES (1) ES436648A1 (2)
FI (1) FI751128A7 (2)
FR (1) FR2267773B1 (2)
GB (1) GB1461209A (2)
HU (1) HU173052B (2)
IE (1) IE41143B1 (2)
IL (1) IL47095A (2)
LU (1) LU72306A1 (2)
NL (1) NL7504570A (2)
NO (1) NO144071C (2)
PH (1) PH11722A (2)
SE (1) SE417965B (2)
YU (1) YU96075A (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
ATE538794T1 (de) * 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
JP4982685B2 (ja) * 2001-12-03 2012-07-25 バイエル、ファーマシューテイカルズ、コーポレイション ヒトがんを処置するための他の細胞毒剤又は細胞増殖抑制剤と組合わせたアリール尿素化合物
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
MXPA04007830A (es) * 2002-02-11 2005-07-01 Bayer Pharmaceuticals Corp Arilureas como inhibidores de cinasa.
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
WO2004113274A2 (en) * 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
EA010485B1 (ru) * 2003-07-23 2008-10-30 Байер Фамэсьютиклс Копэрейшн Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
CN101010315A (zh) * 2004-04-30 2007-08-01 拜耳制药公司 用于治疗癌症的取代的吡唑基脲衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
IE41143B1 (en) 1979-10-24
DE2516554A1 (de) 1975-10-30
AU8013575A (en) 1976-10-21
DK164175A (da) 1975-10-18
IL47095A0 (en) 1975-06-25
GB1461209A (en) 1977-01-13
FI751128A7 (2) 1975-10-18
IE41143L (en) 1975-10-17
DD117223A5 (2) 1976-01-05
AR208545A1 (es) 1977-02-15
YU96075A (en) 1983-04-27
NO751351L (2) 1975-10-20
IL47095A (en) 1978-03-10
NO144071B (no) 1981-03-09
LU72306A1 (2) 1976-03-17
ES436648A1 (es) 1977-08-01
SE417965B (sv) 1981-04-27
NO144071C (no) 1981-06-17
FR2267773A1 (2) 1975-11-14
HU173052B (hu) 1979-02-28
PH11722A (en) 1978-05-30
NL7504570A (nl) 1975-10-21
SE7503523L (sv) 1975-10-20
CH611292A5 (2) 1979-05-31
US4009847A (en) 1977-03-01
CA1047042A (en) 1979-01-23
FR2267773B1 (2) 1978-08-18

Similar Documents

Publication Publication Date Title
FR2267773B1 (2)
BR7501663A (2)
FR2267284B1 (2)
FR2279332B1 (2)
FI52912B (2)
CS177555B1 (2)
CS169567B1 (2)
CS175050B1 (2)
CH580500A5 (2)
CH595903A5 (2)
CH588768A5 (2)
CH587970A5 (2)
CH586802A5 (2)
CH589183A5 (2)
CH586372A5 (2)
CH586159A5 (2)
CH586111A5 (2)
CH584823A5 (2)
CH584502A5 (2)
CH591028A5 (2)
CH580469A5 (2)
DD122820A5 (2)
DD117117A1 (2)
DD116863A2 (2)
CH591633A5 (2)